Beranda › Disfungsi Ventrikel Kiri › Pennsylvania › Pittsburgh
Uji klinis Disfungsi Ventrikel Kiri di Pittsburgh, PA
3 studi untuk Disfungsi Ventrikel Kiri mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- Children's Hospital of Pittsburgh ( Site 0010), Pittsburgh
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- UPMC Children's Hospital of Pittsburgh - Cardiology, Pittsburgh
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- UPMC Children's Hospital of Pittsburgh - Cardiology, Pittsburgh
Uji klinis Disfungsi Ventrikel Kiri di kota lain
- New York City, NY4 studi
- Cleveland, OH4 studi
- Atlanta, GA3 studi
- The Bronx, NY3 studi
- St. Louis, MO3 studi
- Aurora, CO3 studi
- Dallas, TX3 studi
- Houston, TX3 studi
- Philadelphia, PA3 studi
- Cincinnati, OH3 studi
- Ann Arbor, MI3 studi
- Boston, MA3 studi
Studi lain di Pittsburgh
- Kanker Paru Non-Sel Kecil48 studi
- Kanker (semua jenis)41 studi
- Kanker Payudara39 studi
- Kanker Kolorektal32 studi
- Melanoma31 studi
- Kanker Metastatik31 studi
- Kanker Ovarium30 studi
- Kanker Prostat23 studi
- Kanker Paru23 studi
- Kanker Endometrium23 studi
- Stroke22 studi
- Karsinoma Sel Skuamosa Kepala dan Leher22 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.